Gleditsia Linn is widely distributed in the world and Gleditsia sinensis as an important Leguminosae specie, especially its thorns, has been used in the Chinese medicine as a chief ingredient for centuries. While the lack of genome database limits its in-depth research, especially genetic regulation and molecular developmental mechanism. In this investigation, a chromosome-level de novo genome of G. sinensis was assembled through PacBio HiFi, Illumina sequencing as well as those from Hi-C, genetic mapping and K-mer analysis. The G. sinensis harbors 786.13 Mb sized genome (contig N50=1.58 Mb, scaffold N50=51.53 Mb, 2n=28) with 36, 408 protein-coding genes. The full-length transcriptome sequencing of diverse tissues was performed to assist genome functional annotation. The comparative and evolutionary analysis unveiled that G. sinensis diverged from the Cretaceous period approximately 76.31 million years ago (Mya) and the close relationship between G. sinensis and other 8 Leguminosae species. The whole-genome duplication (WGD) analysis indicated G. sinensis underwent three WGD events and might go through another WGD event after differentiating from other Leguminosae plants. The Weighted Gene Coexpression Network Analysis based on phenotype and differentially expressed genes further demonstrated that GsinMYB should be involved in the development of thorns via regulating late thorn differentiation. This investigation provides a high level genome of Gleditsia for Leguminosae species evolution comparison and functional elucidation and also key insights for further study on the molecular regulation mechanisms of the thorns development as a special abnormal stem organ in plants and the molecular breeding of G. sinensis .
Gleditsia sinensis Lam. (G. sinensis) is a widely known medicinal plant, and its primary bioactive compound is gleditsioside. So far, the significant economic and medicinal value of gleditsioside has been widely recognized. However, the transcriptional regulation governing the biosynthesis of gleditsioside during G. sinensis pod development remains unclear. In this investigation, we observed that gleditsioside levels increased in the pods of G. sinensis from June to November, and we performed a transcriptome analysis to explore the phenomenon. A total of 703 and 162 differentially expressed unigenes (DEGs) were identified in the terpenoid backbone and triterpenoid biosynthesis pathways, respectively. In total, 99 unigenes encoding 17 enzymes, such as ENIN, cytochrome P450 (CYP93E1), and UDP-glucosyltransferase, were identified in the gleditsioside biosynthesis pathway. Moreover, DEGs encoding crucial enzymes, such as HMGCR and AGBH, might determine gleditsioside synthesis during G. sinensis pod development. Interestingly, the gleditsioside synthesis pathway extended to ten metabolic pathways, including the sterol biosynthesis pathway and the brassinolide biosynthesis pathway, among other pathways involved in various hormonal regulations. These pathways shared the same precursor substances (IPP and DMAPP). In addition, weighted gene correlation network analysis (WGCNA) revealed that CL5845.Contig1 (HMGCR) and CL8823.Contig2 (LUP4) might be involved in the gleditsioside biosynthesis. Furthermore, transient transformation validation experiments demonstrated overexpression of CL5845.Contig1 (HMGCR), CL8823.Contig2 (LUP4), and CL11248.Contig4 (CYP93E1) significantly enhanced gleditsioside biosynthesis. Overall, our findings provide important genetic resources for future functional research and new insights into the basic mechanism of saponin biosynthesis.